But heres what most of us forget to note about those testimonials: by their very nature, theyre subjective accounts
Unfortunately, despite significant advances in anti-glycemic therapies, macrovascular complications are still the most common cause of death in T2D patients [5]
Hydration strategies for people who can barely eat Some people on GLP-1 medications go through periods where eating feels nearly impossible
Someone with a favorable GLP1R genetic profile may experience minimal nausea, while another person might need 68 weeks of gradual adjustment
This is often compounded if they are starting at a dose higher than 0.25 mg
Nonetheless, in published research to date, ipamorelin administration has produced minimal side effects in animal and human studies alike [11, 12]